MidAmerica Healthcare Venture Forum IBF-International Business Forum


Agenda

Tuesday, September 30th
5:00-6:30 p.m.

Welcome Reception


 
Wednesday, October 1st
7:30-8:45 a.m.

Breakfast & Networking Reception

8:45-9:00 a.m.

Welcome & Opening Remarks

Conference Chairman:
Peter Kleinhenz
Managing Director
CID Capital

Host Committee Chair:
Carol Frankenstein
President
BIOSTART
 
9:00-9:45 a.m.

Conference Keynote Address:
The State of the Healthcare Marketplace

Robbie Huffines
Co-head of Global Healthcare Investment Banking Group
J.P. Morgan Chase
 
9:45-10:45 a.m.

Coast-to-Coast Venture Capital Healthcare Investing:
Who’s doing what, where, and why?

Some of the most active healthcare VCs from across the country will discuss investment trends and strategies regionally and nationally.
  • What kind of deals are they going after and where are they finding them?
  • What are the perceived advantages/disadvantages of companies based in the Midwest vs. the East & West Coasts?

Moderator:
Baiju Shah
President & CEO
BioEnterprise, Inc.
 
Panelists:
Sanuj Ravindran, M.D.
Principal
Radius Ventures

Fred M. Schwarzer
Managing Partner
Charter Life Science

David Darst
Associate
OrbiMed Advisors

Anupendra Sharma
Investment Partner
Siemens Venture Capital
10:45-11:15 a.m.

Networking & Refreshment Break

11:15-12:30 p.m.

Presenting Company Showcase


Track 1: Biotechnology & Pharmaceutical Company Showcase
Time
11:15-11:25
 
11:25-11:35
 
11:35-11:45
 
11:45-11:55
 
11:55-12:05
 
12:05-12:15
 
12:15-12:25
 
Presenter
Joseph Gardner
CEO
Claire Deselle
President & CEO
Fred J. Roisen, PhD
Co-founder, President & CEO
Loren G Peterson
President & CEO
Thomas A. Collet
President & CEO
Mark Olesnavage
CEO
Trevor M. Twose, PhD
CEO

 
Track 2: Biotechnology & Pharmaceutical Company Showcase
Time
11:15-11:25
 
11:25-11:35
 
11:35-11:45
 
11:45-11:55
 
11:55-12:05
 
Presenter
Audra Stinchcomb, PhD
Founder & CEO
David R. Volk
CEO
Andrew Steen
VP, Business Development
Frank Bedu-Addo
President & CEO
Tom Swegle
CEO

 
Track 3: Medical Device Company Showcase
Time
11:15-11:25
 
11:25-11:35
 
11:35-11:45
 
11:45-11:55
 
11:55-12:05
 
12:05-12:15
 
12:15-12:25
 
Presenter
David B. Wortman
Chairman
Clint Dederick
Chairman & CEO
Gary Conkright
CEO
Michael Litscher
CEO & COO
Len Cosentino
VP Business Development
Raymond F. Vennare
Co-Founder & CEO
Jediah White
Director of Business Development

 
12:30-2:00 p.m.

Luncheon with Keynote

Maribeth Rahe
President & CEO
Fort Washington Investment Advisors, Inc.
Sponsored By
P&G Health Care

 
Healthcare and Private Equity: A Perspective from a National Fun of Funds Investor

2:00-3:00 p.m.

Presenting Company Showcase


Track 1: Medical Diagnostic Company Showcase
Time
2:00-2:10
 
2:10-2:20
 
2:20-2:30
 
2:30-2:40
 
2:40-2:50
 
2:50-3:00
 
Presenter
Shawn Lyndon
Founder & CEO
Maria Perr
Director of Marketing
Mark T. Byrne
CEO
Irene Hrusovsky
President & CEO
Eli Thomssen
President & CEO
Mark Pomeranz
President

 
Track 2: Medical Device Company Showcase
Time
2:00-2:10
 
2:10-2:20
 
2:20-2:30
 
2:30-2:40
 
Presenter
Bill Sanford
Chairman & CEO
Herb Senft
President
Jeffrey M. Williams
CEO
Chris Boue
CEO

 
Track 3: Biotechnology & Pharmaceutical Company Showcase
Time
2:00-2:10
 
2:10-2:20
 
2:20-2:30
 
2:30-2:40
 
2:40-2:50
 
2:50-3:00
 
Presenter
G. Lee Southard, PhD
Chairman & CEO
Rahul Aras
President & CEO
Wade Lange
President & CEO
William R. Clarke, MD
President & CEO
Steven Downey
President & CEO
Buddy Lyons
CFO

 
3:00-3:30 p.m.

Networking & Refreshment Break


3:30-4:30 p.m.

The Winner’s Circle:
What it takes to make it to the finish line?

This session will highlight some of the prominent M&A and IPO transactions from across the Midwest over the past year.  What made these deals significant and how did they come together?
 
Moderators:
Mina Patel Sooch, M.B.A.
Founder and Managing Director
Apjohn Ventures

Kathy Tune
Associate
Thomas McNerney Partners

 
Award Recipients:
Bonnie Baskin
Former CEO & Founder
Apptec USA

Bob Palay
Former Chairman & Co-Founder
NimbleGen, Inc.

 
John Neis
Co-Founder & Managing Director
Venture Investors LLC
Board Director, Tomo Therapy
John McIlwraith
Managing Director
Blue Chip Venture Company
Board Member, Renal Solutions

 
Honorable Recognition:
Esperion Therapeutics, Inc.

Nanosphere, Inc.

 
4:30-5:30 p.m.

Navigating the Current Fundraising Landscape

In this session, we will gain insights and perspectives on fundraising issues and techniques from a major consulting group, two well-known fund of funds managers and a branded VC with a successful IR program:
  • How can regional funds better position themselves, given an overall LP bias for East-West Coast VCs?
  • What are the elements of a winning presentation?
  • Fundraising “Do’s and Don’ts”, beginning with initial contact to follow up
  • Between fundraising cycles, how do fund managers build their brand and maintain LP visibility?

Moderator:
Bonnie R. Plunkett
Managing Director
Alternative Investment Source LLC
 
Panelists:
Avinash N. Amin, MD
Senior Vice President
Summit Strategies Group

Mark T. Regal
Director, Customized Fund Investment Group
Credit Suisse

 
Kate Sidebottom Simpson
Vice President
Parish Capital
Spencer L. Timm
Investor Relations Partner
Morgenthaler Ventures

 
5:30-6:30 p.m.

Cocktail Reception


 
Thursday, October 2nd
8:00-9:00 a.m.

Breakfast & Networking Reception

9:00-10:00 a.m.

Corporate Strategic Investing & Acquisitions:
What are they looking for?

Business development executives from medical device, diagnostic, pharmaceutical and biotech companies will discuss:
  • What types of technologies and healthcare sectors are they focused on for investments, alliances, or acquisitions?
  • At what stage in the company’s development will they evaluate the company for investment or acquisition?
  • How would they decide to invest in a venture round versus acquire the company?
Moderator:
Jan Garfinkle
Managing Director
Arboretum Ventures

 
Panelists:
Matt Alves
VP of Program Development
Stryker Instruments

Kevin Driscoll
Director, Global New Business & Technology Development
Procter & Gamble Pharmaceuticals

 
Dan Sheehan
Vice President
Covidien Ventures
Gary Noonan
Senior Director Corporate Business Development
Eli Lilly

 
10:00-11:00 a.m.

Presidential Candidates Healthcare Policy Debate

Moderator:
John Sheils
Senior Vice President
The Lewin Group

 
Presidential Candidate Representatives:

Michael C. Burgess, M.D.
US Congressman
State of Texas

Kevin Grumbach, M.D.
Professor and Chair of the Department of Family and Community Medicine
University of California, San Francisco
Chief of Family and Community Medicine
San Francisco General Hospital
 
11:00-11:30 a.m.

Networking & Reception Break

11:30-12:30 a.m.

Presenting Company Showcase


Track 1: Biotech Company Showcase
Time
11:30-11:40
 
11:40-11:50
 
11:50-12:00
 
12:00-12:10
 
12:10-12:20
 
Company
Chromatin Inc.
 
Bexion Pharmaceuticals, LLC
 
Venomix, Inc.
 
Ausio Pharmaceuticals
 
Esclapeus Biopharmaceuticals
 
Presenter
Daphne Preuss
President & CEO
Ray Takigiku, PhD
President & CEO
John McIntyre
President & CEO
Richard L. Jackson
President & CEO
Dr. Khew-Voon Chin
Founder & Interm CEO

 
Track 2: MedTech Company Showcase
Time
11:30-11:40
 
11:40-11:50
 
11:50-12:00
 
12:00-12:10
 
12:10-12:20
 
12:20-12:30
 
Company
OrthoData, Inc.
 
Accord Biomaterials, Inc.
 
AxioMed Spine Corporation
 
NeuWave Medical, Inc.
 
Sword Diagnostics
 
TissueGen
 
Presenter
Tim Prell
President & CEO
Kris Aalto
President
Patrick McBrayer
President & CEO
Laura G. King
President & CEO
David Dingott
President
Keith W. Brown
President & CEO
12:30-1:45 p.m.

Luncheon with Closing Keynote

Joe Morgan, C.F.A.
Chief Investment Officer and Head of Portfolio Management
SVB Asset Management

The Economic Environment:
  • How is the government working with a conclusion of our outlook for recovery into the foreseeable future?
  • What are their efforts to prop up the financial system?

1:45 p.m.

Program Adjourns

AGENDA IS TENTATIVE AND IS SUBJECT TO CHANGE WITHOUT NOTICE